Success rates and estimation of gestational age for medical abortion vary with transvaginal ultrasonographic criteria

被引:9
作者
Creinin, MD [1 ]
Jerald, H [1 ]
机构
[1] Univ Pittsburgh, Magee Womens Hosp, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA
关键词
abortion; methotrexate; misoprostol; ultrasonography;
D O I
10.1016/S0002-9378(99)70146-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Our purpose was to evaluate differences in gestational age and success rates for medical abortion patients obtained by using several nomograms for mean sac diameter and embryonic pole. STUDY DESIGN: A retrospective review of 1011 patients was performed; the data were from 8 published studies and private patients of the primary author (M.D.C.) who received methotrexate and misoprostol for abortion. The ultrasonographic findings at baseline examination were used to estimate gestational age according to criteria established by Hellman et al and Rossavik et al for mean sac diameter and Robinson, Hadlock et al, and Goldstein and Wolfson for the embryonic pole. The assigned gestational ages of the study population were then compared, and the success rates of treatment at Various gestational ages were calculated for each of the dating criteria. RESULTS: Outcomes on the basis of gestational age for those patients who had only a gestational sac were similar regardless of which gestational age criteria were used. The final assessment of gestational age by embryonic pole according to the criteria of Goldstein and Wolfson was significantly different from the others. CONCLUSIONS: Medical abortion outcomes will vary depending on which criteria are used for establishing gestational age by both mean sac diameter and embryonic pole.
引用
收藏
页码:35 / 41
页数:7
相关论文
共 18 条
[1]   METHOTREXATE AND MISOPROSTOL FOR EARLY ABORTION [J].
CREININ, MD ;
DARNEY, PD .
CONTRACEPTION, 1993, 48 (04) :339-348
[2]   Methotrexate effects on trophoblast and the corpus luteum in early pregnancy [J].
Creinin, MD ;
Stewart-Akers, AM ;
DeLoia, JA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (03) :604-609
[3]   METHOTREXATE AND MISOPROSTOL VS MISOPROSTOL ALONE FOR EARLY ABORTION - A RANDOMIZED CONTROLLED TRIAL [J].
CREININ, MD ;
VITTINGHOFF, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (15) :1190-1195
[4]   Medical abortion with oral methotrexate and vaginal misoprostol [J].
Creinin, MD ;
Vittinghoff, E ;
Schaff, E ;
Klaisle, C ;
Darney, PD ;
Dean, C .
OBSTETRICS AND GYNECOLOGY, 1997, 90 (04) :611-616
[6]   Methotrexate pharmacokinetics and effects in women receiving methotrexate 50 mg and 60 mg per square meter for early abortion [J].
Creinin, MD ;
Krohn, MA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 177 (06) :1444-1449
[7]   Medical abortion with methotrexate 75 mg intramuscularly and vaginal misoprostol [J].
Creinin, MD .
CONTRACEPTION, 1997, 56 (06) :367-371
[8]   Oral methotrexate and vaginal misoprostol for early abortion [J].
Creinin, MD .
CONTRACEPTION, 1996, 54 (01) :15-18
[9]   Methotrexate and misoprostol for early abortion: A multicenter trial .1. Safety and efficacy [J].
Creinin, MD ;
Vittinghoff, E ;
Keder, L ;
Darney, PD ;
Tiller, G .
CONTRACEPTION, 1996, 53 (06) :321-327
[10]   Effects of methotrexate on trophoblast proliferation and local immune responses [J].
DeLoia, JA ;
Stewart-Akers, AM ;
Creinin, MD .
HUMAN REPRODUCTION, 1998, 13 (04) :1063-1069